Clinical Trials Directory

Trials / Unknown

UnknownNCT05174533

Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Université de Reims Champagne-Ardenne · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.

Detailed description

The aim of the study is to describe prevalence of cardiovascular disorders in patients aged 40 and more with schizophrenia.

Conditions

Interventions

TypeNameDescription
OTHERData collectionelectrocardiogram

Timeline

Start date
2022-01-12
Primary completion
2022-05-12
Completion
2022-07-12
First posted
2021-12-30
Last updated
2022-02-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05174533. Inclusion in this directory is not an endorsement.

Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia (NCT05174533) · Clinical Trials Directory